{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:46:41Z","timestamp":1785876401349,"version":"3.56.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["K23MH138746"],"award-info":[{"award-number":["K23MH138746"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007911","name":"University of California San Diego","doi-asserted-by":"publisher","award":["RG114131"],"award-info":[{"award-number":["RG114131"]}],"id":[{"id":"10.13039\/100007911","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jad.2026.122107","type":"journal-article","created":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T14:26:40Z","timestamp":1780842400000},"page":"122107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Comparing transcranial magnetic stimulation and esketamine treatment response trajectories in resistant depression"],"prefix":"10.1016","volume":"412","author":[{"given":"Lindsay L.","family":"Benster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan N.","family":"Kohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Wade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah","family":"Stapper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cory R.","family":"Weissman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Miron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zafiris J.","family":"Daskalakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence G.","family":"Appelbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2026.122107_bb0005","first-page":"1327","article-title":"Esketamine following transcranial magnetic stimulation for treatment resistant depression","volume":"15","author":"Al-Sabbagh","year":"2022","journal-title":"Brain Stimul. Basic Transl. Clin. Res. Neuromodulation"},{"key":"10.1016\/j.jad.2026.122107_bb0010","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41386-022-01370-w","article-title":"Synaptic plasticity and mental health: methods, challenges and opportunities","volume":"48","author":"Appelbaum","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2026.122107_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41398-025-03380-w","article-title":"Predictive modeling of response to repetitive transcranial magnetic stimulation in treatment-resistant depression","volume":"15","author":"Benster","year":"2025","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2026.122107_bb0020","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/070674370705200108","article-title":"Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods","volume":"52","author":"Berlim","year":"2007","journal-title":"Can. J Psychiatr. Rev. Can. Psychiatr."},{"key":"10.1016\/j.jad.2026.122107_bb0025","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1001\/jamapsychiatry.2016.3644","article-title":"Repetitive transcranial magnetic stimulation for the acute treatment of major depressive episodes: a systematic review with network Meta-analysis","volume":"74","author":"Brunoni","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2026.122107_bb0030","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1176\/appi.focus.17105","article-title":"Efficacy and safety of intranasal Esketamine for the rapid reduction of symptoms of depression and suicidality in patients at imminent risk for suicide: results of a double-blind, randomized, placebo-controlled study","volume":"17","author":"Canuso","year":"2019","journal-title":"FOCUS"},{"key":"10.1016\/j.jad.2026.122107_bb0035","doi-asserted-by":"crossref","first-page":"190","DOI":"10.9758\/cpn.2021.19.2.190","article-title":"Personalization of repetitive transcranial magnetic stimulation for the treatment of major depressive disorder according to the existing psychiatric comorbidity","volume":"19","author":"Chou","year":"2021","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.jad.2026.122107_bb0040","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/hup.2475","article-title":"The use of ketamine as an antidepressant: a systematic review and meta-analysis","volume":"30","author":"Coyle","year":"2015","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"key":"10.1016\/j.jad.2026.122107_bb0045","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.brs.2012.08.006","article-title":"New targets for rTMS in depression: a review of convergent evidence","volume":"6","author":"Downar","year":"2013","journal-title":"Brain Stimulat."},{"key":"10.1016\/j.jad.2026.122107_bb0050","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0006-3223(03)00231-2","article-title":"Diagnosis and definition of treatment-resistant depression","volume":"53","author":"Fava","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2026.122107_bb0055","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19m13191","article-title":"Esketamine nasal spray for rapid reduction of major depressive disorder symptoms in patients who have active suicidal ideation with intent: double-blind, randomized study (ASPIRE I)","volume":"81","author":"Fu","year":"2020","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2026.122107_bb0060","first-page":"331","article-title":"Treatment outcome predictors from TMS\/fMRI, trauma history, and brain state manipulations in depression and PTSD","volume":"18","author":"Garcia","year":"2025","journal-title":"Brain Stimul. Basic Transl. Clin. Res. Neuromodulation"},{"key":"10.1016\/j.jad.2026.122107_bb0065","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/YCO.0b013e32835ab46d","article-title":"The expanding evidence base for rTMS treatment of depression","volume":"26","author":"George","year":"2013","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.jad.2026.122107_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1275","article-title":"Concomitant medication use and clinical outcome of repetitive transcranial magnetic stimulation (rTMS) treatment of major depressive disorder","volume":"9","author":"Hunter","year":"2019","journal-title":"Brain Behav."},{"key":"10.1016\/j.jad.2026.122107_bb0075","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/ijnp\/pyaa068","article-title":"Esketamine nasal spray for rapid reduction of depressive symptoms in patients with major depressive disorder who have active suicide ideation with intent: results of a phase 3, double-blind, randomized study (ASPIRE II)","volume":"24","author":"Ionescu","year":"2021","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2026.122107_bb0080","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.1007\/s11357-025-01615-8","article-title":"Innovative approaches in the treatment-resistant depression: exploring different therapeutic pathways","volume":"47","author":"\u0141ysik","year":"2025","journal-title":"GeroScience"},{"key":"10.1016\/j.jad.2026.122107_bb0085","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jad.2022.09.043","article-title":"Real-world experience of esketamine use to manage treatment-resistant depression: a multicentric study on safety and effectiveness (REAL-ESK study)","volume":"319","author":"Martinotti","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122107_bb0090","article-title":"A retrospective naturalistic study comparing the efficacy of ketamine and repetitive transcranial magnetic stimulation for treatment-resistant depression","volume":"12","author":"Mikellides","year":"2022","journal-title":"Front. Psychol."},{"key":"10.1016\/j.jad.2026.122107_bb0095","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial","volume":"170","author":"Murrough","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.122107_bb0100","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.biopsych.2007.01.018","article-title":"Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial","volume":"62","author":"O\u2019Reardon","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2026.122107_bb0105","first-page":"1041","article-title":"Comparing fast-acting interventions for treatment-resistant depression: an explorative study of accelerated HF-rTMS versus intranasal esketamine","volume":"16","author":"Pettorruso","year":"2023","journal-title":"Brain Stimul. Basic Transl. Clin. Res. Neuromodulation"},{"key":"10.1016\/j.jad.2026.122107_bb0110","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1176\/appi.ajp.2019.19020172","article-title":"Efficacy and safety of flexibly dosed Esketamine nasal spray combined with a newly initiated Oral antidepressant in treatment-resistant depression: a randomized double-blind active-controlled study","volume":"176","author":"Popova","year":"2019","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.122107_bb0115","doi-asserted-by":"crossref","DOI":"10.1080\/13651501.2026.2642680","article-title":"Fast-acting approaches for treatment-resistant depression: real-world comparative effectiveness of intranasal Esketamine versus accelerated rTMS","author":"Prato","year":"2026","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"10.1016\/j.jad.2026.122107_bb0120","doi-asserted-by":"crossref","first-page":"949","DOI":"10.3390\/brainsci14090949","article-title":"Repetitive transcranial magnetic stimulation for the treatment of depression in a real-world setting: findings from a cohort study","volume":"14","author":"Prodi","year":"2024","journal-title":"Brain Sci."},{"key":"10.1016\/j.jad.2026.122107_bb0125","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.122107_bb0130","first-page":"141","article-title":"Repetitive transcranial magnetic stimulation for the treatment of suicidal ideation in a naturalistic setting","volume":"18","author":"Stapper","year":"2025","journal-title":"Brain Stimul. Basic Transl. Clin. Res. Neuromodulation"},{"key":"10.1016\/j.jad.2026.122107_bb0135","doi-asserted-by":"crossref","first-page":"341","DOI":"10.9758\/cpn.2021.19.2.341","article-title":"Rapid onset of intranasal Esketamine in patients with treatment resistant depression and major depression with suicide ideation: a Meta-analysis","volume":"19","author":"Wang","year":"2021","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.jad.2026.122107_bb0140","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726009596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726009596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:06:31Z","timestamp":1785873991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032726009596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":28,"alternative-id":["S0165032726009596"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2026.122107","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing transcranial magnetic stimulation and esketamine treatment response trajectories in resistant depression","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2026.122107","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"122107"}}